Vitamin D3
Dietary Supplementvitamin D3 supplementation at 400 IU vs 1,000 IU vs 2,000 IU vs 4,000 IU vs placebo for 12-weeks
NCT Number: NCT00931580
While a large percentage of children have low blood vitamin D levels, the significance of these low levels and the impact on health is unclear. The purpose of this project is to determine the effects of varying doses of vitamin D supplementation over 12 weeks on blood indicators of health in white and black children, aged 9 to 13 years, from both the northern and southern US.
Looking for future studies?
Notify Me9 year–13 year
All sexes
Interventional
Not applicable
The University of Georgia Dept of Foods & Nutrition, Athens, Georgia, United States
Vitamin D intakes in children do not meet current US Dietary Reference Intake recommendations and emerging evidence suggests that a significant number of children, particularly those with darker skin pigmentation, have inadequate levels of serum 25-hydroxyvitamin D [25(OH)D]. The optimum level of circulating 25(OH)D has not been clearly defined in children, nor is it known what functional outcome measures are ideal for defining this level, or if these requirements would differ by race. Graded doses of vitamin D3 supplementation will be used in this dual-site, 12-week trial. The investigators hypothesize that a dose-response relationship will be observed between vitamin D supplementation and intermediate endpoints of skeletal health, and that race will modify these responses.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
vitamin D3 supplementation at 400 IU vs 1,000 IU vs 2,000 IU vs 4,000 IU vs placebo for 12-weeks
Time frame: 0 weeks
Time frame: 0 weeks
Time frame: 0 weeks
Time frame: 0 weeks
Time frame: 0 weeks
Time frame: 3 weeks
Time frame: 6 weeks
Time frame: 9 weeks
Time frame: 12 weeks
Time frame: 3 weeks
Time frame: 6 weeks
Time frame: 9 weeks
Time frame: 12 weeks
Time frame: 3 weeks
Time frame: 6 weeks
Time frame: 9 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 3 weeks
Time frame: 6 weeks
Time frame: 9 weeks
Time frame: 12 weeks
Time frame: 0 weeks
Time frame: 0 weeks
Time frame: 0 weeks
Time frame: 0 weeks
Time frame: 0 weeks
Time frame: 3 weeks
Time frame: 6 weeks
Time frame: 9 weeks
Time frame: 12 weeks
Time frame: 3 weeks
Time frame: 6 weeks
Time frame: 9 weeks
Time frame: 12 weeks
Time frame: 3 weeks
Time frame: 6 weeks
Time frame: 9 weeks
Time frame: 12 weeks
Time frame: 3 weeks
Time frame: 6 weeks
Time frame: 9 weeks
Time frame: 12 weeks
Time frame: 3 weeks
Time frame: 6 weeks
Time frame: 9 weeks
Time frame: 12 weeks
University of Georgia
Other
Supplemental Vitamin D and Functional Outcomes in Early Adolescence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details